PUBLICATIONS

Full list of published work: NCBI My Bibliography or ORCID: 0000-0002-0857-2973

Most recent listed first:

2024

Frey, Z.D, D.A. Price*, K.A. Connors*, R.E. Rush*, G. Brown, C.E. Sterling, F. Fatma, M.M. Schwarz, S. Ganaie, X. Cui, Z.P. Wills, D.W. Leung, G.K. Amarasinghe, A.L. Hartman. Lrp1 facilitates infection of neurons by Jamestown Canyon virus. Posted 11/7/24. bioRxiv https://www.biorxiv.org/content/10.1101/2024.11.06.622176v1. (Preprint)

Connors, K.A., M.R. Pedlow, Z.D. Frey, J.J. McGaughey, G.K. Amarasinghe, W.P. Duprex, L. D’Aiuto, Z.P. Wills, and A.L. Hartman. Posted 10/12/24. bioRxiv https://www.biorxiv.org/content/10.1101/2024.10.11.617875v1. (Preprint)

Connors, K.A., N.S. Chapman, C.M. McMillen, R.M. Hoehl, J.J. McGaughey, Z.D. Frey, M. Midgett, C. Williams, D.S. Reed, J.E. Crowe, Jr., and A.L. Hartman. 2024. Potent neutralizing human monoclonal antibodies protect from Rift Valley fever encephalitis. JCI Insight. 9(18):e180151. https://doi.org/10.1172/jci.insight.180151 Published 8/1/2024 . PMID: 39088277.

McMillen, C.M., C. Megli, R. Radisic, L.B. Skvarca, R.M. Hoehl, D.A. Boyles, J.J. McGaughey, B.H. Bird, A.K. McElroy, and A.L. Hartman. 2024. Vaccine strains of Rift Valley fever virus exhibit attenuation at the maternal-fetal placental interface. Journal of Virology. Published July 2024. PMID: 39016561. DOI: 10.1128/jvi.00983-24.

Griesman, T., C.M. McMillen, S.G. Negatu, J. Hulahan, K. Whig, L. Dohnalova, M. Dittmar, C.A. Thaiss, K.A. Jurado, D.C. Schults, A.L. Hartman, and S. Cherry. 2024. The lipopeptide Pam3CSK4 inhibits Rift Valley fever virus infection and protects from encephalitis. PLoS Pathog 20(6): e1012343. Published July 2024. PMID: 38935789 PMCID: PMC11236204. https://doi.org/10.1371/journal.ppat.1012343.

Nambulli, S, N. Escriou, L.J. Rennick, M.J. Demers, N.L. Tilston-Lunel, A.K. McElroy, D.J. Barbeau, N.A. Crossland, R.M. Hoehl, S. Schrauf, A.G. White, H.J. Borish, J.A. Tomko, L.J. Frye, C.A. Scanga, J.L. Flynn, A. Martin, C. Gerke, A.L. Hartman, W.P. Duprex. 2024. A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to Phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. Journal of Virology. Apr 2:e0176223. PMID: 38563762. DOI: 10.1128/jvi.01762-23.

Connors, K.A., Z.D. Frey, M.J. Demers, Z.P. Wills, A.L. Hartman. 2024. Rift Valley fever virus infection induces inflammatory cytokines and cell death in ex vivo rodent brain slice culture. Journal of General Virology. 105:001970. Published 3/28/24. https://doi.org/10.1099/jgv.0.001970.

2023:

Rasmussen AL, Gronvall GK, Lowen AC, Goodrum F, Alwine J, Andersen KG, Anthony SJ, Baines J, Banerjee A, Broadbent AJ, Brooke CB, Campos SK, Caposio P, Casadevall A, Chan GC, Cliffe AR, Collins-McMillen D, Connell N, Damania B, Daugherty MD, Debbink K, Dermody TS, DiMaio D, Duprex WP, Emerman M, Galloway DA, Garry RF, Goldstein SA, Greninger AL, Hartman AL, Hogue BG, Horner SM, Hotez PJ, Jung JU, Kamil JP, Karst SM, Laimins L, Lakdawala SS, Landais I, Letko M, Lindenbach B, Liu S-L, Luftig M, McFadden G, Mehle A, Morrison J, Moscona A, Mühlberger E, Munger J, Münger K, Murphy E, Neufeldt CJ, Nikolich JZ, O'Connor CM, Pekosz A, Permar SR, Pfeiffer JK, Popescu SV, Purdy JG, Racaniello VR, Rice CM, Runstadler JA, Sapp MJ, Scott RS, Smith GA, Sorrell EM, Speranza E, Streblow D, Tibbetts SA, Toth Z, Van Doorslaer K, Weiss SR, White EA, White TM, Wobus CE, Worobey M, Yamaoka S, Yurochko A. 2024. Virology-the path forward. J Virol. 2024 Jan 3:e0179123. doi: 10.1128/jvi.01791-23. Epub ahead of print. PMID: 38168672.

Ganaie SS, Leung DW, Hartman AL, Amarasinghe GK. Host entry factors of Rift Valley Fever Virus infection. Adv Virus Res. 2023;117:121-136. doi: 10.1016/bs.aivir.2023.09.001. Epub 2023 Oct 5. PubMed PMID: 37832991; PubMed Central PMCID: PMC11312830.

Hartman, A.L. and Peter J. Myler. Bunyavirales: Scientific Gaps and Prototype Pathogens for a Large and Diverse Group of Zoonotic Viruses. 2023. The Journal of Infectious Diseases, Volume 228, Issue Supplement 6, 15 October 2023, Pages S376–S389, https://doi.org/10.1093/infdis/jiac338. PMID: 37849397.

McMillen, C.M., N.S. Chapman, R.M. Hoehl, L.B. Skvarca, M.M. Schwarz, L.S. Handal, J.E. Crowe, Jr., and A.L. Hartman. 2023. A highly potent human neutralizing antibody prevents vertical transmission of Rift Valley fever virus in a rat model. Nature Communications. 14: 4507. Published online 26 July 2023. https://doi.org/10.1038/s41467-023-40187-z.

Schwarz, M.M, S.S. Ganaie, A. Feng, G. Brown, T. Yangdon, J.M. White, R.M. Hoehl, C.M. McMillen, R.E. Rush, K.A. Connors, X. Cui, D.W. Leung, T. Egawa, G.K. Amarasinghe, A.L. Hartman. 2023. Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice. Science Advances. 9(28):eadh226. DOI: 10.1126/sciadv.adh2264. PMID: 37450601. Epub 2023 Jul 14.

Gardner, C.L., C. Sun, M.D. Dunn, T.C. Gilliland, Jr., D.W. Trobaugh, Y. Terada, D.S. Reed, A.L. Hartman, and W.B. Klimstra. 2023. In Vitro and In Vivo Phenotypes of Venezuelan, Eastern and Western Equine Encephalitis Viruses Derived from cDNA Clones of Human Isolates. Viruses. 15(1):5. https://doi.org/10.3390/v15010005. PMID: 36680046.

2022:

McMillen, C.M., D.A. Boyles, S.G. Kostadinov, R.M. Hoehl, M.M. Schwarz, J.R. Albe, M. Demers, and A.L. Hartman. 2022. Congenital Rift Valley fever in Sprague Dawley rats is associated with diffuse infection and pathology of the placenta. PLoS Negl Trop Dis 16(10): e0010898. PMID: 36315601. https://doi.org/10.1371/journal.pntd.0010898.

Schwarz, M.M., K.A. Connors, K.A. Davoli, C.M. McMillen, J.R. Albe, R.M. Hoehl, M.J. Demers, S.S. Ganaie, D.A. Price, D.W. Leung, G.K. Amarasinghe, A.K. McElroy, D.S. Reed, and A.L. Hartman. 2022. Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease. Journal of Virology. 96(20):e01112-22. PMID: 36194021. https://doi.org/10.1128/jvi.01112-22.

Connors, K.A., and A.L. Hartman. 2022. Advances in Understanding Neuropathogenesis of Rift Valley Fever Virus. Annu. Rev. Virol. 9:437–50. PMID: 36173701. https://doi.org/10.1146/annurev-virology-091919-065806.

Schwarz, M.S., D.A. Price, S.S. Ganaie, A. Feng, N. Mishra, R.M. Hoehl, S.H. Stubbs, S.P.J. Whelan, X. Cui, T. Egawa, D.W. Leung, G.K. Amarasinghe, and A.L. Hartman. 2022. Oropouche orthobunyavirus infection is mediated by the cellular host factor Lrp1. PNAS. 119 (33) e2204706119. PMID: 35939689. https://doi.org/10.1073/pnas.220470611.

Ma, H., J.R. Albe, T. Gilliland, C.M. McMillen, C.L. Gardner, D.A. Boyles, E.L. Cottle, M.D. Dunn, J.D. Lundy, N. Salama, K.J. O’Malley, I. Pandrea, T. Teichert, S. Barrick, W.B. Klimstra, A.L. Hartman, and D.S. Reed. 2022. Long-term persistence of viral RNA and inflammation in the CNS of macaques exposed to aerosolized Venezuelan equine encephalitis virus. PLoS Pathogens 18(6): e1009946. PMID: 35696423 DOI: 10.1371/journal.ppat.1009946

2021:

Ganaie, S.S., M.M. Schwarz, C.M. McMillen, D. Price, A. Feng, J.R. Albe, W. Wang, S. Miersch, A. Ovredahl, A.R. Cole, M.F. Sentmanat, N. Mishra, D.A. Boyles, Z.T. Koenig, M.R. Kujawa, M.A. Demers, R.M. Hoehl, A. Moyle, N. Wagner, S.H. Stubbs, L. Cardarelli, J. Teyra, A.K. McElroy, M.L. Gross, S.P.J. Whelan, J. Doench, X. Cui, T.J. Brett, S.S. Sidhu, H.W. Virgin, T. Egawa, D.W. Leung, G.K. Amarasinghe, and A.L. Hartman. Lrp1 is a host entry factor for Rift Valley Fever Virus. Cell. 184(20):5163-5178.e24. Published online 23 September 2021. PMID: 34559985. https://doi.org/10.1016/j.cell.2021.09.001. **Commentary can be found at DOI:https://doi.org/10.1016/j.cell.2021.09.004.

McMillen, C.M., and A.L. Hartman. 2021. Rift Valley fever: a threat to pregnant women hiding in plain sight? Journal of Virology GEM (invited). 95(9):e01394-19. May 2021. PMID: 33597209. https://jvi.asm.org/content/early/2021/02/12/JVI.01394-19 .

Albe, J.R., H.M. Ma, T.G. Gilliland, C.M. McMillen, C.L. Gardner, D.A. Boyles, E.L. Cottle, M.D. Dunn, J. Lundy, K.J. O’Malley, N. Salama, A.W. Walters, I. Vasile-Pandrea, T. Teichert, W.B. Klimstra, D.S. Reed, and A.L. Hartman. 2021. Physiological and immunological changes in the brain associated with lethal eastern equine encephalitis virus in macaques. PLOS Pathogens. 17(2): e1009308. Published 2/3/21. PMID: 33534855. https://doi.org/10.1371/journal.ppat.1009308.

2020:

Boyles, D.A., M.M. Schwarz, J.R. Albe, C.M. McMillen, K.J. O’Malley, D.S.Reed, and A.L. Hartman. 2020. Development of Rift valley fever encephalitis in rats is mediated by early infection of olfactory epithelium and neuroinvasion across the cribiform plate. Journal of General Virology. Accepted 10/30/20. Published online 11/24/20. PMID: 33231535. https://doi.org/10.1099/jgv.0.001522.

Barbeau, D.J., J.R. Albe, S. Nambulli, N.L. Tilston-Lunel, A.L. Hartman, S.S. Lakdawala, E. Klein, W.P. Duprex, and A.K. McElroy. 2020. Rift Valley fever virus infection causes acute encephalitis in the ferret. mSphere. 5(5):e00798-20. PMID: 33115835. https://msphere.asm.org/content/5/5/e00798-20

Muñoz-Fontela C, Dowling WE, Funnell SGP, Gsell PS, Riveros-Balta AX, Albrecht RA, Andersen H, Baric RS, Carroll MW, Cavaleri M, Qin C, Crozier I, Dallmeier K, de Waal L, de Wit E, Delang L, Dohm E, Duprex WP, Falzarano D, Finch CL, Frieman MB, Graham BS, Gralinski LE, Guilfoyle K, Haagmans BL, Hamilton GA, Hartman AL, Herfst S, Kaptein SJF, Klimstra WB, Knezevic I, Krause PR, Kuhn JH, Le Grand R, Lewis MG, Liu WC, Maisonnasse P, McElroy AK, Munster V, Oreshkova N, Rasmussen AL, Rocha-Pereira J, Rockx B, Rodríguez E, Rogers TF, Salguero FJ, Schotsaert M, Stittelaar KJ, Thibaut HJ, Tseng CT, Vergara-Alert J, Beer M, Brasel T, Chan JFW, García-Sastre A, Neyts J, Perlman S, Reed DS, Richt JA, Roy CJ, Segalés J, Vasan SS, Henao-Restrepo AM, Barouch DH. 2020. Animal models for COVID-19. Nature. 2020 Oct;586(7830):509-515. Epub 2020 Sep 23. Review. PubMed PMID: 32967005. https://www.nature.com/articles/s41586-020-2787-6.

Hartman AL, Nambulli S, McMillen CM, White AG, Tilston-Lunel NL, Albe JR, Cottle E, Dunn MD, Frye LJ, Gilliland TH, Olsen EL, O’Malley KJ, Schwarz MM, Tomko JA, Walker RC, Xia M, Hartman MS, Klein E, Scanga CS, Flynn JL, Klimstra WB, McElroy AK, Reed DS, and Duprex WP. 2020. SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts. PLOS Pathogens 2020 Sep;16(9):e1008903. PMID: 32946524. https://doi.org/10.1371/journal.ppat.1008903.

Klimstra WB, Tilston-Lunel NL, Nambulli S, Boslett J, McMillen CM, Gilliland T, Dunn MD, Sun C, Wheeler SE, Wells A, Hartman AL, McElroy AK, Reed DS, Rennick LJ, Duprex WP. 2020. SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients. PMID: 33115835. Journal of General Virology. 101(11). https://doi.org/10.1099/jgv.0.001481 .

Fears, A.C., W.B. Klimstra, P.D. Duprex, A.L. Hartman, S.C. Weaver, K.S. Plante, D. Mirchandani, J. Plante, P.V. Aguilar, D. Fernandez, A. Nalca, A. Totura, D. Dyer, B. Kearney, M. Lackemeyer, J.K. Bohannon, R. Johnson, R.F. Garry, D.S. Reed, C.J. Roy. 2020. Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions. Emerging Infectious Diseases. 26(9): Sept 2020. PMID: 32568661. https://wwwnc.cdc.gov/eid/article/26/9/20-1806_article

Ma, H., J.D. Lundy, E.L. Cottle, K.J. O’Malley, A.M. Trichel, W.B. Klimstra, A.L. Hartman, D.S. Reed, T. Teichert. 2020. Applications of minimally invasive multimodal telemetry for continuous monitoring of brain function and intracranial pressure in macaques with acute viral encephalitis. PLoS One 15(6): e0232381. PMID: 32584818. https://doi.org/10.1371/journal.pone.0232381

2019:

Ma, H., J.D. Lundy, K.J. O’Malley, W.B. Klimstra, A.L. Hartman, and D.S. Reed. 2019. Electrocardiography Abnormalities in Macaques after Infection with Encephalitic Alphaviruses. Pathogens. 8(4), 240. https://doi.org/10.3390/pathogens8040240.

Bowling, J.D., K.J. O’Malley, W.B. Klimstra, A.L. Hartman, and D.S. Reed. 2019. A vibrating mesh nebulizer as an alternative to the Collison 3-jet nebulizer for infectious disease aerobiology. Applied and Environmental Microbiology. 85(17):e00747-19. https://doi.org/10.1128/AEM.00747-19.

Albe, J.R., D.A. Boyles, A.W. Walters, M.R. Kujawa, C.M. McMillen, D.S. Reed, and A.L. Hartman. 2019. Neutrophil and macrophage influx into the central nervous system are inflammatory components of lethal Rift Valley Fever encephalitis in rats. PLOS Pathogens. June 20, 2019. 15(6):e1007833. https://doi.org/10.1371/journal.ppat.1007833.

Walters, A.W., M.R. Kujawa, J.R. Albe, W.B. Klimstra, and A.L. Hartman. 2019. Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats. Virology 526:173-179. https://doi.org/10.1016/j.virol.2018.10.021

2018:

McMillen, C.M., N. Arora, D.A. Boyles, J.R. Albe, M.R. Kujawa, J.F. Bonadio, C.B. Coyne, and A.L. Hartman. 2018. Rift Valley fever virus induces fetal demise through direct placental infection. Science Advances 4(12):eaau9812. PMID: 30525107. http://advances.sciencemag.org/content/4/12/eaau9812.

McMillen, CM, and A.L. Hartman. 2018. Rift Valley fever in animals and humans: Current perspectives. Antiviral Research. 156:29-37. https://doi.org/10.1016/j.antiviral.2018.05.009

Lane WC, Dunn MD, Gardner CL, Lam LKM, Watson AM, Hartman AL, Ryman KD, Klimstra WB. 2018. The efficacy of the interferon alpha/beta response versus arboviruses is temperature dependent. mBio 9:e00535-18. https://doi.org/10.1128/mBio.00535-18

Wonderlich, E.R., A.L. Caroline, C.M. McMillen, A.W. Walters, D.S. Reed, S.M. Barratt-Boyes, and A.L. Hartman. 2018. Peripheral blood biomarkers of disease outcome in a monkey model of Rift Valley Fever encephalitis. Journal of Virology 92(3):e01662-17, PMID: 29118127 doi:10.1128/JVI.01662-17.

2017:

Koday, M.T., J.A. Leonard, P. Munson, A. Forero, M. Koday, D.L. Bratt, J.T. Fuller, R. Murnane, S. Qin, T.A. Reinhart, K. Duus, I. Messaoudi, A.L. Hartman, K.S. Cole, J. Morrison, M.G. Katze, and D.H. Fuller. 2017. Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates. PLOS One. 12(12):e0189780. https://doi.org/10.1371/journal.pone.0189780.

Hartman A.L. Rift Valley Fever. Clinics in Laboratory Medicine. 2017;37(2):285-301. doi: https://doi.org/10.1016/j.cll.2017.01.004.

Wonderlich, E.R., Z.D Swan, S.J. Bissel, A.L. Hartman, J.P. Carney, K.J. O’Malley, A.O. Obadan, J. Santos,, R. Walker, T.J. Sturgeon, L.J. Frye Jr, P. Maiello, C.A. Scanga, J.D. Bowling, A.L. Bouwer, P.A. Duangkhae, C.A. Wiley, J.L. Flynn, J. Wang, K.S. Cole, D.R. Perez, D.S. Reed, and S.M. Barratt-Boyes. 2017. Widespread virus replication in alveoli drives acute respiratory distress syndrome in aerosolized H5N1 influenza infection of macaques. Journal of Immunology. 198. DOI: https://doi.org/10.4049/jimmunol.1601770

2016:

Caroline, A.L., M.R. Kujawa, T. Oury, D.S. Reed, and A.L. Hartman. 2016. Inflammatory biomarkers associated with lethal Rift Valley fever encephalitis in the Lewis rat model. Frontiers in Microbiology. 6:1509. https://doi.org/10.3389/fmicb.2015.01509.

2015:

Mirza, S.K., T.R. Tragon, M.B. Fukui, M.S. Hartman, and A.L. Hartman. 2015. Microbiology for Radiologists: How to Minimize Infection Transmission in the Radiology Department. RadioGraphics. 45(4). DOI: http://dx.doi.org/10.1148/rg.2015140034

2014:

Caroline, A.L., D.S. Powell, L.M. Bethel, T.D. Oury, D.S. Reed, and A.L. Hartman. 2014. Broad spectrum antiviral activity of Favipiravir (T-705): Protection from highly lethal inhalational Rift Valley Fever. PLOS Neglected Tropical Diseases. 8(4):e2790. https://doi.org/10.1371/journal.pntd.0002790.

Reed, D.S., Bethel, L.M., Powell, D.S., A.L. Hartman. 2014. Differences in aerosolization of Rift Valley Fever virus resulting from choice of inhalation exposure chamber: implications for animal challenge studies. Pathogens & Disease. https://doi.org/10.1111/2049-632X.12157.

Powell, D.S., R.C. Walker, D.T. Heflin, D. Fisher, J.B. Kosky, L.C. Homer, D.S. Reed, K.S. Cole, A.M. Trichel, and A.L. Hartman. 2014. Development of novel mechanisms for housing, handling, and remote monitoring of common marmosets at animal biosafety level 3. Pathogens & Disease. https://doi.org/10.1111/2049-632X.12140.

Hartman, A.L., Powell, D.S., Bethel, L.M., Caroline, A.L., Schmid, R.J., Oury, T., and Reed, D.S. 2014. Aerosolized Rift Valley Fever virus causes fatal encephalitis in African green monkeys and common marmosets. Journal of Virology 88(4):2235-2245. https://doi.org/10.1128/JVI.02341-13.

2012:

Narayanan, A., K. Kehn-Hall, S. Senina, L. Lundberg, R. Van Duyne, I. Guendel, R. Das, A. Baer, L. Bethel, M. Turell, A.L. Hartman, B. Das, M.S. Navati, A.J. Friedman, J.M. Friedman, C. Bailey, and F. Kashanchi. 2012. Curcumin inhibits Rift Valley Fever Virus replication in human cells. Journal of Biological Chemistry. 287(40):33198-33214.

Bales, J.M., D.S. Powell, L.M. Bethel, D.S. Reed, and A.L.Hartman. 2012. Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus. Frontiers in Cellular Infection Microbiology. 2(105):1-14.

Hartman, A.L., K.S. Cole, and L.C. Homer. 2012. Verification of Inactivation Methods for Removal of Biological Materials from a Biosafety Level-3 Select Agent Facility. Applied Biosafety: Journal of the American Biological Safety Association. 17(2):70-75.

Earlier:

Homer, L.C., A.L. Hartman, D.T. Heflin, A.M. Trichel, D.S. Reed, and K.S. Cole. 2011. Enhancement of the Mentored Training Program for Investigative Staff at the University of Pittsburgh Regional Biocontainment Laboratory. Applied Biosafety: Journal of the American Biological Safety Association. 16(4):231-239.

Hartman, A.L., L.C. Homer, A.M. Trichel, D. Fisher, J. Frerotte, and K.S. Cole. 2010. Evolution of a Facility-Specific BSL-3 Training Program for the University of Pittsburgh Regional Biocontainment Laboratory. Applied Biosafety: Journal of the American Biological Safety Association. 15(3):137-141.

Bird, B.H., J. Githinji, J. Macharia, J. Kasiiti, R.M. Muriithi, S.G. Gacheru, J.O. Musaa, J.S. Towner, S.A. Reeder, J.B. Oliver, T.L. Stevens, B.R. Erickson, L.T. Morgan, M.L. Khristova, A.L. Hartman, J.A. Comer, P.E. Rollin, T.G. Ksiazek, and S.T. Nichol. 2008. Multiple virus lineages sharing recent common ancestry were associated with a large Rift Valley fever outbreak among livestock in Kenya during 2006-2007. Journal of Virology 82(22):11152 - 11166.

Hartman, A.L., L. Ling, S.T. Nichol, and M.L. Hibberd. 2008. Whole Genome Expression Profiling Reveals that Inhibition of the Host Innate Immune Response by Ebola Virus can be Reversed by a Single Amino Acid Change in the VP35 Protein. Journal of Virology 82(11): 5348-5358.

Hartman, A.L., B.H. Bird, J.S. Towner, Z. Antoniadou, S. Zaki, and S.T. Nichol. 2008. Inhibition of IRF-3 activation by VP35 is critical for the high virulence of Ebola virus. Journal of Virology 82(6):2699-2704.

Bird, B.H., C. Albarino, A.L. Hartman, B. Erickson, T. Ksiazek, and S.T. Nichol. 2008. Rift Valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals. Journal of Virology 82(6):2681-2691.

Hartman, A.L., J. E. Dover, J. S. Towner, and S. T. Nichol. 2006. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. Journal of Virology. 80(13):6430-6440.

Towner, J. S., M. L. Khristova, M. Vincent, T. K. Sealy, B. R. Erickson, D. Bawiec, A.L. Hartman, A. Comer, S. Zaki, H. Feldmann, P. Rollin, T. G. Ksiazek, and S. T. Nichol. 2006. Emergence of Marburg Virus in Angola, West Africa. Journal of Virology. 80(13):6497-6516.

Cárdenas, W. B., Y.-M. Loo, M. Gale Jr., A. L. Hartman, and C. F. Basler. 2006. Ebola virus VP35 protein binds dsRNA and inhibits interferon α/β production induced by RIG-I signaling. Journal of Virology. 80(11):5168-78.

Reid, S.R., L. W. Leung, A. L. Hartman, O. Martinez, M. L. Shaw, C. Carbonnelle, V. E. Volchkov, S. T. Nichol, and C. F. Basler. 2006. Ebola virus VP24 Binds Karyopherin-alpha1 and Blocks STAT1 Nuclear Accumulation. Journal of Virology. 80(11):5156-67.

Hartman, A. L., J. S. Towner, and S. T. Nichol. 2004. A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. Virology. 328:177-184.